Morepen Laboratories Ltd NSE  /  BSE

Pharmaceuticals, Mid Cap

16 Feb 2018 | 03:59 PM

35.55
-0.45 (-1.25%)

  • Outperforms Index

    72.57%

    Return (1Y)

    Beaten S&P BSE Healthcare by 77.96%

  • More Volatile

    3.84%

    Standard Deviation (1Y)

    Higher than S&P BSE Healthcare by 2.8%

  • Not so consistent

    4/12

    Months

    underperformed S&P BSE Healthcare

  • AxisDirect View

    No View

52 Week High-Low

44

44.35

15

14.80

News & Announcements

Price vs Volume

Stock Trivia

  • FII shareholding in Morepen Laboratories Ltd has decreased by -100% since past 3 Months

  • FII shareholding in Morepen Laboratories Ltd has decreased by -100% since past 1 Year

  • GovT shareholding in Morepen Laboratories Ltd has decreased by -100% since past 1 Year

Loading...